In the present study we present a new method that allows for the selection
of protein interactions in mammalian cells. We have used this system to ver
ify two interactions previously characterized in vitro. (1) The interaction
between human TATA-binding protein 1 and nuclear factor kappa B and (2) th
e association of Homo sapiens nuclear autoantigen SP100B with human hetero
chromatin protein Ice, a protein implicated in chromatin remodelling. We ob
serve for the first time that these interactions also occur in vivo. One pr
otein was fused to the N-terminal half of ubiquitin, while the interacting
partner was fused to the C-terminal half of ubiquitin, that was itself link
ed to guanine phosphoryltransferase 2 (gpt2) modified to begin with an argi
nine residue. Upon interaction of both proteins, ubiquitin is reconstituted
, and its association with the Rgpt2 reporter is subsequently cleaved off b
y ubiquitin-processing enzymes. presence of arginine in the Rgpt2 gene prod
uct leads to the degradation of the product by the N-end rule pathway. In t
he human fibroblast cell line HT1080HPRT(-) (that is deficient in the enzym
e for hypoxanthine-guanine phosphoribosyltransferase) cells in which intera
ction between both proteins of interest occurs can then be selected for by
hypoxanthine/aminopterin/thymine medium and counterselected against by 6-th
ioguanine medium. This method provides a suitable alternative to the yeast
two-hybrid system and is generally applicable.